Scientific publications
Respiratory co-and superinfections in COVID-19
J L Del Pozo 1
Abstract
There are few publications on the impact of coinfection and superinfection in patients with COVID-19. Patients with higher severity are much more prone to secondary bacterial, fungal or viral infections.
The overuse of antimicrobials in many viral infections (including SARS-CoV-2 infections) undoubtedly contributes to the current antimicrobial resistance crisis. In the context of COVID-19, we are witnessing an increase in multidrug-resistant bacterial infections in our hospitals.
The heterogeneity of published studies makes it critical to perform more large-scale studies to better understand the pathogenesis of coinfections or superinfections in the COVID-19 patient.
CITATION Rev Esp Quimioter. 2021 Sep;34 Suppl 1:69-71. doi:10.37201/req/s01.20.2021. Epub 2021 Sep 30.
Our authors
